药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Galsulfase
Eliglustat
The metabolism of Eliglustat can be decreased when combined with Boceprevir.
Pramlintide
Oliceridine
The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Gabapentin enacarbil is combined with Oliceridine.
Pramlintide
Lasmiditan
The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with Lasmiditan.
Pramlintide
Esketamine
The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with Esketamine.
Pramlintide
Cannabinol
The risk or severity of adverse effects can be increased when Cannabinol is combined with Gabapentin enacarbil.
Pramlintide
Palmidrol
The risk or severity of adverse effects can be increased when Palmidrol is combined with Gabapentin enacarbil.
Pramlintide
Nabiximols
The risk or severity of adverse effects can be increased when Nabiximols is combined with Gabapentin enacarbil.
Pramlintide
WIN 55212-2
The risk or severity of adverse effects can be increased when WIN 55212-2 is combined with Gabapentin enacarbil.
Pramlintide
Surinabant
The risk or severity of adverse effects can be increased when Surinabant is combined with Gabapentin enacarbil.
Pramlintide
Ibipinabant
The risk or severity of adverse effects can be increased when Ibipinabant is combined with Gabapentin enacarbil.
Pramlintide
Ajulemic acid
The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Gabapentin enacarbil.
Pramlintide
GW842166
The risk or severity of adverse effects can be increased when GW842166 is combined with Gabapentin enacarbil.
Pramlintide
Cannabidiol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Gabapentin enacarbil.
Pramlintide
Taranabant
The risk or severity of adverse effects can be increased when Taranabant is combined with Gabapentin enacarbil.
Pramlintide
Rimonabant
The risk or severity of adverse effects can be increased when Rimonabant is combined with Gabapentin enacarbil.
Pramlintide
SLV319
The risk or severity of adverse effects can be increased when SLV319 is combined with Gabapentin enacarbil.
Pramlintide
Potassium cation
Potassium cation may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.
Pramlintide
Potassium
Potassium may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.
Pramlintide
Bromotheophylline
Bromotheophylline may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.
Pramlintide
Epitizide
Epitizide may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.